First Time Loading...
T

Teva Pharmaceutical Industries Ltd
NYSE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Watchlist
Price: 13.81 USD 4.23% Market Closed
Updated: Apr 27, 2024
Section:
 

Relative Value

The Relative Value of one TEVA stock under the Base Case scenario is 28.1 USD. Compared to the current market price of 13.81 USD, Teva Pharmaceutical Industries Ltd is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TEVA Relative Value
Base Case
28.1 USD
Undervaluation 51%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
7
vs Industry
72
Median 3Y
0.7
Median 5Y
0.7
Industry
2.4
Forward
0.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-4.4
Industry
22.9
Forward
534.6
More Details
10.7
P/OCF
P/OCF
Price to OCF
10.7
vs History
44
vs Industry
34
Median 3Y
9.5
Median 5Y
10.1
Industry
17.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
17
Median 3Y
-7.5
Median 5Y
-7.4
Industry
23.2
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
3
vs Industry
41
Median 3Y
1.2
Median 5Y
1.1
Industry
2.1
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
50
vs Industry
55
Median 3Y
1.8
Median 5Y
1.9
Industry
2.6
Forward
1.8
More Details
3.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.7
vs History
71
vs Industry
52
Median 3Y
3.7
Median 5Y
3.9
Industry
5.1
More Details
6.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.3
vs History
61
vs Industry
44
Median 3Y
6.2
Median 5Y
6.6
Industry
13.6
Forward
6.1
More Details
8.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
8.3
vs History
79
vs Industry
40
Median 3Y
8.6
Median 5Y
9.5
Industry
17
Forward
7.1
More Details
21.6
EV/OCF
EV/OCF
Enterprise Value to OCF
21.6
vs History
79
vs Industry
21
Median 3Y
24.5
Median 5Y
26.1
Industry
15.8
More Details
35.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
35.1
vs History
65
vs Industry
14
Median 3Y
36.6
Median 5Y
45.7
Industry
17.6
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
3
vs Industry
66
Median 3Y
0.7
Median 5Y
0.7
Industry
1.9
More Details

Multiples Across Competitors

TEVA Competitors Multiples
Teva Pharmaceutical Industries Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
55.5B USD 0.9 -26.1 6.3 8.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
696.4B USD 20.4 132.9 60.1 68.9
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 17 47.2 34.6 37.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
351.8B USD 4.3 8.7 11.6 15.3
US
Merck & Co Inc
NYSE:MRK
332.2B USD 5.5 910 45.2 88.2
UK
AstraZeneca PLC
LSE:AZN
185.8B GBP 5.1 39 140.5 225.4
CH
Novartis AG
SIX:NOVN
182.9B CHF 4.3 13.5 9.9 16.3
CH
Roche Holding AG
SIX:ROG
176.2B CHF 3 15.3 8.5 10

See Also

Summary
TEVA intrinsic value, competitors valuation, and company profile.
DCF Valuation
TEVA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TEVA stock valuation using valuation multiples.
Wall Street Estimates
TEVA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TEVA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.